20 results
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
9:06am
with the employees of the Company or any of its subsidiaries, or, to the knowledge of the Company, with the employees of any principal supplier, manufacturer
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
19 Jan 24
Entry into a Material Definitive Agreement
4:19pm
of the Company, with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or is threatened or imminent
424B3
PROK
ProKidney Corp - Ordinary Shares
21 Apr 23
Prospectus supplement
4:18pm
or export hold-up) or supplier error;
inability to have enough manufacturing slots to manufacture cell therapies for patients as and when those … require us to find an alternative manufacturer or supplier for one or more components that we need in the manufacture of REACT, which would in turn
POS AM
kowpdo4699io
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
aidx3 cef
9 Sep 22
Prospectus supplement
5:05pm
8-K
EX-10.5
3rvue7s2lv v8
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFM14A
0pwat29
10 Jun 22
Proxy related to merger
4:54pm
PRER14A
nylaum20n68llr1l8j
11 Apr 22
Preliminary revised proxy
5:29pm
10-K
EX-14.1
y6piswl 3q1md0gfxrg
23 Mar 22
Annual report
5:32pm
PREM14A
7cev1b
14 Feb 22
Preliminary proxy related to merger
4:55pm
DEFA14A
k2t4of337y
21 Jan 22
Additional proxy soliciting materials
4:38pm
8-K/A
EX-2.1
884xeiim6t45stg8
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-1.1
hw742m9ra4opz
2 Jul 21
Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
4:22pm
S-1
EX-14
eypx89x 032t92
2 Jun 21
IPO registration
5:17pm
- Prev
- 1
- Next